HealthEquity Financial Statements From 2010 to 2024

HQY Stock  USD 79.20  0.67  0.84%   
HealthEquity financial statements provide useful quarterly and yearly information to potential HealthEquity investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on HealthEquity financial statements helps investors assess HealthEquity's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting HealthEquity's valuation are summarized below:
Gross Profit
490.1 M
Profit Margin
0.0557
Market Capitalization
6.9 B
Enterprise Value Revenue
7.4133
Revenue
999.6 M
We have found one hundred twenty available fundamental trends for HealthEquity, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to confirm all of HealthEquity regular market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road.

HealthEquity Total Revenue

1.05 Billion

Check HealthEquity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HealthEquity main balance sheet or income statement drivers, such as Depreciation And Amortization of 160.7 M, Interest Expense of 58.2 M or Selling General Administrative of 108.8 M, as well as many exotic indicators such as Price To Sales Ratio of 6.57, Dividend Yield of 0.0735 or PTB Ratio of 5.76. HealthEquity financial statements analysis is a perfect complement when working with HealthEquity Valuation or Volatility modules.
  
This module can also supplement HealthEquity's financial leverage analysis and stock options assessment as well as various HealthEquity Technical models . Check out the analysis of HealthEquity Correlation against competitors.
For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.

HealthEquity Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.4 B3.2 B1.3 B
Slightly volatile
Other Current Liabilities54.8 M95.6 M44.2 M
Slightly volatile
Total Current Liabilities79 M117.1 M63.8 M
Slightly volatile
Total Stockholder Equity2.1 BB793.3 M
Slightly volatile
Other Liabilities115.2 M109.7 M47.9 M
Slightly volatile
Accounts Payable6.9 M12 M5.6 M
Slightly volatile
Cash212.6 M404 M169.6 M
Slightly volatile
Other Assets0.951.014.2 M
Slightly volatile
Good WillB1.9 B658.8 M
Slightly volatile
Common Stock Shares Outstanding68.4 M87 M60.4 M
Slightly volatile
Other Current Assets51 M48.6 M19.9 M
Slightly volatile
Total Liabilities609.8 M1.2 B485.7 M
Slightly volatile
Intangible Assets428.2 M835.9 M343.8 M
Slightly volatile
Common Stock6.5 KK5.3 K
Slightly volatile
Property Plant Equipment83.7 M79.7 M33.6 M
Slightly volatile
Property Plant And Equipment Net47.5 M54.4 M35.3 M
Slightly volatile
Non Current Assets Total2.8 B2.7 B1.1 B
Slightly volatile
Cash And Short Term Investments243.5 M404 M181.3 M
Slightly volatile
Net Receivables52.6 M104.9 M39.7 M
Slightly volatile
Common Stock Total Equity6.2 K9.2 K5.3 K
Slightly volatile
Liabilities And Stockholders Equity1.6 B3.2 B1.2 B
Slightly volatile
Non Current Liabilities Total578.7 M1.1 B426.7 M
Slightly volatile
Other Stockholder Equity1.9 B1.8 B677.9 M
Slightly volatile
Property Plant And Equipment Gross51.6 M95.4 M38.3 M
Slightly volatile
Total Current Assets320 M557.4 M239.4 M
Slightly volatile
Capital Surpluse1.4 B1.3 B601.5 M
Slightly volatile
Non Current Liabilities Other18.3 M19.3 M99.3 M
Pretty Stable
Net Invested Capital2.2 B2.9 B1.2 B
Slightly volatile
Long Term Investments562.4 K630 K689.4 K
Slightly volatile
Net Working Capital298.8 M440.3 M261 M
Slightly volatile
Capital Stock8.4 KK6.8 K
Slightly volatile
Short and Long Term Debt Total849.9 M933.1 M1.2 B
Slightly volatile
Long Term Debt Total945.3 M1.1 B1.2 B
Slightly volatile
Capital Lease Obligations59.7 M58.2 M77.1 M
Slightly volatile
Short and Long Term Debt25.6 M15.8 M34.7 M
Slightly volatile
Short Term Debt8.9 M9.4 M43.9 M
Slightly volatile

HealthEquity Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization160.7 M153.1 M58.6 M
Slightly volatile
Selling General Administrative108.8 M103.7 M43.5 M
Slightly volatile
Selling And Marketing Expenses83.2 M79.3 M34 M
Slightly volatile
Total RevenueB999.6 M402.9 M
Slightly volatile
Gross Profit556.4 M529.9 M226 M
Slightly volatile
Other Operating Expenses915 M871.5 M350.9 M
Slightly volatile
Operating Income134.5 M128.1 M49.7 M
Slightly volatile
EBIT134.5 M128.1 M49.6 M
Slightly volatile
Research Development229.8 M218.8 M75.6 M
Slightly volatile
EBITDA295.3 M281.2 M108.2 M
Slightly volatile
Cost Of Revenue493.2 M469.7 M176.9 M
Slightly volatile
Total Operating Expenses421.8 M401.7 M174 M
Slightly volatile
Reconciled Depreciation103.2 M153.1 M58.1 M
Slightly volatile
Interest Income12.7 M12.1 M5.9 M
Pretty Stable
Non Recurring43 M52.9 M37 M
Slightly volatile

HealthEquity Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation81 M77.2 M27.2 M
Slightly volatile
Begin Period Cash Flow176.1 M254.3 M140.5 M
Slightly volatile
Depreciation160.7 M153.1 M57.3 M
Slightly volatile
Capital Expenditures52.1 M46.1 M41.7 M
Slightly volatile
Total Cash From Operating Activities255 M242.8 M94.2 M
Slightly volatile
End Period Cash Flow212.6 M404 M169.6 M
Slightly volatile
Change To Netincome55.2 M52.6 M20.9 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio6.576.46967.3986
Slightly volatile
Dividend Yield0.07350.070.0581
Slightly volatile
PTB Ratio5.763.17784.8151
Very volatile
Days Sales Outstanding30.5638.301836.7665
Slightly volatile
Book Value Per Share24.9723.783611.8425
Slightly volatile
Invested Capital0.780.43461.0461
Slightly volatile
Operating Cash Flow Per Share2.982.83791.7321
Slightly volatile
Stock Based Compensation To Revenue0.04090.07720.0437
Slightly volatile
PB Ratio5.763.17784.8151
Very volatile
EV To Sales6.986.9997.1404
Slightly volatile
ROIC0.0310.03260.0706
Slightly volatile
Inventory Turnover416396268
Slightly volatile
Days Of Inventory On Hand0.00.02.2178
Slightly volatile
Payables Turnover35.1739.009537.0521
Slightly volatile
Sales General And Administrative To Revenue0.080.10370.0974
Slightly volatile
Average Inventory0.40.450.49
Slightly volatile
Research And Ddevelopement To Revenue0.120.21890.1398
Slightly volatile
Cash Per Share3.254.72143.6886
Pretty Stable
POCF Ratio26.9826.631930.3305
Slightly volatile
Payout Ratio4.684.463.7309
Slightly volatile
Days Payables Outstanding15.779.356717.4868
Slightly volatile
EV To Operating Cash Flow29.1228.811129.5852
Slightly volatile
Intangibles To Total Assets0.420.76750.5181
Slightly volatile
Current Ratio8.24.76076.5144
Very volatile
Receivables Turnover10.659.52969.981
Slightly volatile
Graham Number19.618.666310.1402
Slightly volatile
Shareholders Equity Per Share24.9723.783611.8425
Slightly volatile
Debt To Equity0.780.43461.0461
Slightly volatile
Revenue Per Share12.2711.68237.0949
Slightly volatile
Debt To Assets0.40.27330.4526
Slightly volatile
Enterprise Value Over EBITDA25.2324.878325.9016
Slightly volatile
Short Term Coverage Ratios27.1125.82165.8706
Slightly volatile
Operating Cycle43.8838.301839.8724
Pretty Stable
Price Book Value Ratio5.763.17784.8151
Very volatile
Days Of Payables Outstanding15.779.356717.4868
Slightly volatile
Dividend Payout Ratio4.684.463.7309
Slightly volatile
Price To Operating Cash Flows Ratio26.9826.631930.3305
Slightly volatile
Operating Profit Margin0.180.12820.1628
Slightly volatile
Company Equity Multiplier1.191.59041.4937
Very volatile
Long Term Debt To Capitalization0.430.30070.4878
Slightly volatile
Total Debt To Capitalization0.440.30290.4972
Slightly volatile
Return On Capital Employed0.0390.04110.1261
Slightly volatile
Debt Equity Ratio0.780.43461.0461
Slightly volatile
Ebit Per Revenue0.180.12820.1628
Slightly volatile
Quick Ratio4.134.3466.7552
Very volatile
Net Income Per E B T0.730.74241.0062
Slightly volatile
Cash Ratio6.183.45014.8256
Very volatile
Cash Conversion Cycle20.4428.945121.8742
Slightly volatile
Operating Cash Flow Sales Ratio0.280.24290.2516
Very volatile
Days Of Inventory Outstanding0.00.02.2178
Slightly volatile
Days Of Sales Outstanding30.5638.301836.7665
Slightly volatile
Cash Flow Coverage Ratios0.290.27460.1226
Slightly volatile
Price To Book Ratio5.763.17784.8151
Very volatile
Fixed Asset Turnover25.0418.377124.5864
Slightly volatile
Price Cash Flow Ratio26.9826.631930.3305
Slightly volatile
Enterprise Value Multiple25.2324.878325.9016
Slightly volatile
Debt Ratio0.40.27330.4526
Slightly volatile
Cash Flow To Debt Ratio0.290.27460.1226
Slightly volatile
Price Sales Ratio6.576.46967.3986
Slightly volatile
Asset Turnover0.540.30880.6204
Slightly volatile
Gross Profit Margin0.460.53010.5553
Very volatile
Price Fair Value5.763.17784.8151
Very volatile

HealthEquity Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap4.2 BB3.2 B
Slightly volatile
Enterprise Value5.2 BBB
Slightly volatile

HealthEquity Fundamental Market Drivers

Forward Price Earnings42.3729
Cash And Short Term Investments404 M

HealthEquity Upcoming Events

19th of March 2024
Upcoming Quarterly Report
View
3rd of June 2024
Next Financial Report
View
31st of January 2024
Next Fiscal Quarter End
View
19th of March 2024
Next Fiscal Year End
View
31st of October 2023
Last Quarter Report
View
31st of January 2023
Last Financial Announcement
View

About HealthEquity Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include HealthEquity income statement, its balance sheet, and the statement of cash flows. HealthEquity investors use historical funamental indicators, such as HealthEquity's revenue or net income, to determine how well the company is positioned to perform in the future. Although HealthEquity investors may use each financial statement separately, they are all related. The changes in HealthEquity's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on HealthEquity's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on HealthEquity Financial Statements. Understanding these patterns can help to make the right decision on long term investment in HealthEquity. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue999.6 MB
Cost Of Revenue469.7 M493.2 M
Stock Based Compensation To Revenue 0.08  0.04 
Sales General And Administrative To Revenue 0.10  0.08 
Research And Ddevelopement To Revenue 0.22  0.12 
Capex To Revenue(0.05)(0.05)
Revenue Per Share 11.68  12.27 
Ebit Per Revenue 0.13  0.18 

HealthEquity Investors Sentiment

The influence of HealthEquity's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in HealthEquity. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to HealthEquity's public news can be used to forecast risks associated with an investment in HealthEquity. The trend in average sentiment can be used to explain how an investor holding HealthEquity can time the market purely based on public headlines and social activities around HealthEquity. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
HealthEquity's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for HealthEquity's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average HealthEquity's news discussions. The higher the estimated score, the more favorable is the investor's outlook on HealthEquity.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards HealthEquity in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, HealthEquity's short interest history, or implied volatility extrapolated from HealthEquity options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether HealthEquity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of HealthEquity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Healthequity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Healthequity Stock:
Check out the analysis of HealthEquity Correlation against competitors.
For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for HealthEquity Stock analysis

When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
CEOs Directory
Screen CEOs from public companies around the world
Is HealthEquity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HealthEquity. If investors know HealthEquity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HealthEquity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.96)
Earnings Share
0.64
Revenue Per Share
11.682
Quarterly Revenue Growth
0.122
Return On Assets
0.0256
The market value of HealthEquity is measured differently than its book value, which is the value of HealthEquity that is recorded on the company's balance sheet. Investors also form their own opinion of HealthEquity's value that differs from its market value or its book value, called intrinsic value, which is HealthEquity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HealthEquity's market value can be influenced by many factors that don't directly affect HealthEquity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HealthEquity's value and its price as these two are different measures arrived at by different means. Investors typically determine if HealthEquity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HealthEquity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.